Cargando…
Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
We investigated risk factors for immune-related adverse events (irAEs) in patients treated with anti-programmed cell death protein1 antibody pembrolizumab. A retrospective medical record review was performed to identify all patients who received at least one dose of pembrolizumab at Samsung Medical...
Autores principales: | Eun, Yeonghee, Kim, In Young, Sun, Jong-Mu, Lee, Jeeyun, Cha, Hoon-Suk, Koh, Eun-Mi, Kim, Hyungjin, Lee, Jaejoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773778/ https://www.ncbi.nlm.nih.gov/pubmed/31575933 http://dx.doi.org/10.1038/s41598-019-50574-6 |
Ejemplares similares
-
Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
por: Lee, Seulkee, et al.
Publicado: (2020) -
Increased risk of malignancy in patients with Takayasu’s arteritis: a population-based cohort study in Korea
por: Lee, Seulkee, et al.
Publicado: (2022) -
A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
por: Lee, Seulkee, et al.
Publicado: (2021) -
Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis
por: Lee, Seulkee, et al.
Publicado: (2021) -
Cardiovascular risk associated with allopurinol or benzbromarone
treatment in patients with gout
por: Eun, Yeonghee, et al.
Publicado: (2022)